EMEA’s CHMP Recommends Approval Of Avastin In Metastatic Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Committee also issues positive opinion for Roche’s Xeloda in first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.
You may also be interested in...
EMEA’s CHMP Recommends Approval For Avastin In Kidney Cancer
Renal cell cancer would be the fourth indication gained in the EU for the VEGF-inhibitor; Genentech plans to submit an sBLA for kidney cancer in 2008.
EMEA’s CHMP Recommends Approval For Avastin In Kidney Cancer
Renal cell cancer would be the fourth indication gained in the EU for the VEGF-inhibitor; Genentech plans to submit an sBLA for kidney cancer in 2008.
Novartis/Idenix Tyzeka To Launch Within 30 Days For Treatment Of Hepatitis B
Novartis and Idenix will co-promote telbivudine with separate field forces in the U.S.